Canmab 440 mg Injection

Canmab 440 mg Injection is engineered to tackle aggressive cancers that overexpress the HER2 protein. By blocking the receptors that fuel cell division, Trastuzumab effectively "starves" the tumor. In many cases, it is used in combination with chemotherapy (such as paclitaxel or docetaxel) to provide a comprehensive attack on malignant cells.

Key Clinical Advantages of Biocon Canmab

• Targeted Mechanism: Specifically attacks cancer cells while minimizing damage to healthy, non-HER2-expressing cells.

• Proven Biosimilarity: Clinically tested to show no meaningful differences in safety, purity, or potency compared to Herceptin.

• Improved Survival: Significantly increases progression-free survival (PFS) and overall survival (OS) in both breast and gastric cancer patients.

• Multi-Dose Vial: The 440 mg strength is designed for efficient clinical use and precise weight-based dosing.

Administration & Cold-Chain Protocols

1. Administration: Must be administered as an Intravenous (IV) Infusion by a qualified oncology professional. It is never given as an IV bolus or push.

2. Dosing Schedule: Typically follows a loading dose (e.g., 8 mg/kg) followed by maintenance doses (e.g., 6 mg/kg) every 3 weeks, or weekly schedules depending on the regimen.

3. Strict Storage: Must be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Do not freeze or shake the vial.

4. Monitoring: Patients require regular cardiac monitoring (LVEF assessments), as Trastuzumab can affect heart function, especially when used with anthracyclines.

Frequently Asked Questions (FAQs)

1. Is Canmab 440 mg the same as Herceptin?

   Yes. Canmab is a biosimilar, meaning it has the same active ingredient (Trastuzumab) and clinical efficacy as Herceptin, but is offered at a more accessible price point.

2. How do you ship Canmab to the USA, Canada, or Saudi Arabia?

   Because Canmab is a biologic, it requires strict cold-chain logistics. We use specialized medical-grade insulated packaging and real-time temperature monitoring to ensure it stays between 2°C and 8°C during transit to the USA, Canada, UK, UAE, Saudi Arabia, China, and Russia.

3. What are the most common side effects of Trastuzumab?

   Common side effects include fever, nausea, vomiting, infusion reactions, cough, and headache. Serious but rare side effects include reduced heart function (left ventricular dysfunction) and lung toxicity.

4. Can I take Canmab for any type of breast cancer?

   No. Canmab is only effective for HER2-positive cancers. Your oncologist must confirm your HER2 status via an IHC or FISH test before starting treatment.

5. What is the shelf life of Canmab once reconstituted?

   While the vial includes a preservative, once reconstituted for infusion, it should be used immediately or stored refrigerated for no more than 24 hours (refer to specific manufacturer guidelines).